Potential of Surface-Coil MRI for Staging of Esophageal Cancer
Abstract
OBJECTIVE. The aim of this pilot study was to assess the feasibility of external surfacecoil MRI as a new method of imaging the esophagus and esophageal cancer.
CONCLUSION. The results for the 10 patients investigated indicate that by using a high-resolution axial T2-weighted sequence (small field of view, thin section images), MRI provides detailed imaging of the anatomic layers of the esophageal wall and tumor. Three independent radiologists found good correlation in the morphologic appearance and extent of tumor between MRI and matched histology sections. This study illustrates the potential of the technique as an alternative form of local staging for esophageal cancer.
Introduction
Esophageal cancer is the eighth most common cancer worldwide [1]. In the West, adenocarcinoma is now the predominate form of esophageal cancer, having recently surpassed the incidence of esophageal squamous cell carcinoma [2]. Surgical resection remains the only curative treatment for adenocarcinoma of the esophagus but carries significant morbidity and mortality. It is essential for imaging to accurately identify patients with localized, resectable disease.
Locoregional staging is currently undertaken by CT and endoscopic sonography. The latter is more accurate than CT in determining T stage, with rates between 60% and 80% depending on tumor stage and operator experience [3, 4]. However, endoscopic sonography examinations may be limited by tightly stenosed tumors and differentiation of ulcer-associated inflammation from infiltration [5, 6]. The transducers used are high frequency (7.5-12 MHz) to maximize resolution, but have a restricted sonographic range, limiting visualization of structures that are deep to the tumor. This limits determination of tumor-free surgical resection planes.
To date, MRI has not been used for locoregional staging. An early study [7] comparing conventional CT and 0.35-T MRI found MRI to have lower accuracy for staging esophageal tumors than CT, although a more recent study [8] concluded that MRI and CT had similar accuracy in predicting resectability of tumors in patients with esophageal cancer. However, because CT also provides information regarding distant metastatic disease and is more widely available, it has remained the technique of choice. Technical challenges have to be overcome when using MRI for esophageal imaging—the deep location of the esophagus and the degree of movement related to cardiac motion, peristalsis, and respiration, combined with the relatively slow acquisition time of MRI, conspire to degrade image quality. Recent research has focused mainly on endoluminal MRI because reducing the distance between the coil and the esophagus increases the signal-to-noise ratio, improving image quality. However, limited in vivo and ex vivo studies are available on endoluminal MRI esophageal imaging. Analysis of the optimal sequence indicates that T2-weighted images provide the best delineation of the layers of the esophageal wall [9-12]. To our knowledge, the use of an external surface coil to acquire high-resolution images of the esophagus has not previously been described.
The aim of this pilot study was to establish whether MRI of esophageal cancer is feasible using an externally placed surface coil. We also evaluated the ability of the technique to depict normal esophageal wall and periesophageal planes and to clearly delineate tumor by correlation with histopathology of the resected specimen.
Materials and Methods
Ten patients with confirmed esophageal carcinoma (seven with adenocarcinoma, two with squamous cell carcinoma, and one with spindle-cell melanoma), who were deemed medically fit for surgery and shown to have resectable disease using endoscopic sonography and CT, underwent high-resolution MRI of their primary tumors on the day before surgery. The study group contained 7 men and 3 women with median age of 60 years (range, 47-82 years). Nine patients had preoperative combination chemotherapy, and one patient with spindle cell melanoma underwent primary surgery. Nine patients underwent esophagogastrectomy, and one underwent total gastrectomy and esophagogastrectomy with a colonic interposition. The resections were performed by two surgeons with 16 and 17 years experience in esophageal surgery.


Ethics approval was obtained from the local research ethics committee. Informed, written consent was obtained from each patient.
MRI Technique
Images were acquired using a 1.5-T system (Intera, Philips Medical Systems). T1-weighted and T2-weighted images were evaluated. The four-element Philips Medical Systems sensitivity-encoding (SENSE) phased-array body coil was used for tumors of the lower third of the esophagus and gastroesophageal junction (seven patients); for tumors of the middle third (three patients), elements 1 and 2 of phased-array Synergy Spine Coil (Philips Medical Systems) were used. This minimized the distance between the esophagus and the receiver coil, maximizing the signal-to-noise ratio. The patients were positioned supine, and the body coil was placed over the lower thorax with two elements anterior and two posterior. Initially, a T2-weighted sagittal sequence was acquired to localize the tumor and to plan 3-mm axial images perpendicular to the long axis of the tumor.
Axial sequence parameters for T1-weighted images were as follows: TR/TE, 643/15; field of view, 225; matrix, 200/512; number of signal averages (NSA), 6; turbo spin-echo (TSE) factor, 31. The parameters for T2-weighted images were: 6,000/120; field of view 225; matrix, 208/512; NSA, 6; TSE factor, 31. The in-plane resolution for the T2-weighted sequence was 225/208 × 225/512 (1.08 × 0.44), giving a voxel volume of (1.08 × 0.44 × 3) 1.42 mm3 and for the T1-weighted sequence of 1.48 mm3, thus producing high-resolution images.
A saturation band was placed over the heart, but no cardiac or respiratory gating was used.
MRI Analysis
Three radiologists, who were aware that the patients were considered eligible for surgical resection but were blinded to the endoscopic sonography, CT, and histology reports, independently reviewed the MR images on a workstation (Merge eFilm Workstation 1.9.3, eMed). The images were magnified to the same extent as the corresponding histology section to improve measurement accuracy. The radiologists had 3, 10, and 26 years of cross-sectional imaging experience.
Feasibility of MRI
The following were noted for each patient: whether the scan was tolerated, scan duration, and image quality. Image quality was graded by two interpreters as good (3), moderate (2), or poor (1) for the following parameters: visualization of the esophageal wall and its component layers, visualization of the lumen, and depiction of periesophageal tissues and adjacent structures.
MRI Tumor Assessment
Morphology—Tumor signal intensity, location (mucosal, submucosal, muscularis propria), and position were noted.
Measurements—Normal esophageal wall, tumor thickness, and depth of extramural disease were measured.
Histology section orientation and matching with MR images—Each surgical specimen was fixed by total immersion in buffered formalin, and the lumen was distended with formalin. The circumferential (surgical) resection margin was inked to enable anatomic orientation. The specimen was sectioned transversely at intervals of 5-6 mm, giving sections corresponding with the MR images (each alternate image). Whole-mount glass slides were prepared and stained with H and E.
One interpreter oriented the slides in conjunction with the histopathologist and matched the histology slides with the corresponding MR image. The documented level of the tumor and morphologic appearance of the esophagus were used for matching. The interpreter remained blinded to the exact location and extent of the tumor and final histologic stage. To reduce the impact of any potential unblinding, the interpreter allowed 1 month between matching and recording the study data.
In total for the 10 patients, 50 histology slides with matched MR images were used for recording data.
Histologic analysis—The slides were digitally scanned (Expression 1680 Professional, Seiko Epson). The computerized histology sections were magnified to three times their original size, and measurements identical to those for the MR images were taken. Histologic sections matched with an MR image that showed no macroscopic abnormality were reviewed by the pathologist to establish the extent of the microscopic abnormality.
Statistical Analysis
Bland-Altman plots were used to compare the agreement between measurements of normal wall thickness and tumor thickness. This statistical method allowed comparison of a new measurement technique (MRI) with an established one (histology) and assessment of the extent by which the techniques differ [13]. The same method was applied to assess interobserver variability by analyzing the repeatability of measurements among different interpreters. In this case, the value for 2 SDs from the mean represented the coefficient of repeatability.
When a discrepancy greater than ± 2 mm from the mean difference occurred between MRI and histology for two or more interpreters, the images were reviewed to establish the cause of the discrepancy.
Results
MRI Analysis
Feasibility of MRI—All 10 patients tolerated the scan. The mean axial T2-weighted sequence time was 6.89 ± 1.19 minutes. The mean overall scanning time was 15.74 ± 2.50 minutes.
MRI sequence evaluation—The T1-weighted images were graded as poor. Layers of the esophageal wall were not clearly delineated, tumors could not be identified separate from the surrounding wall, and visualization of periesophageal tissues was poor (Figs. 1A and 1B). As a result, after the first two patients were scanned, only the T2-weighted sequence was run. The T2-weighted sequence provided clear delineation of normal structures. Visualization of the esophageal wall layers was good in four patients and moderate in five. Visualization of the periesophageal tissues was good in four patients and moderate in six. The results are shown in Table 1.
Characteristic | Patient 1 | Patient 2 | Patient 3 | Patient 4 | Patient 5 | Patient 6 | Patient 7 | Patient 8 | Patient 9 | Patient 10 |
---|---|---|---|---|---|---|---|---|---|---|
Esophageal wall | 2 | 2 | 3 | 3 | 3 | 3 | 2 | 3 | 2 | 2 |
Layers of esophageal wall | 2 | 2 | 3 | 3 | 3 | 2 | 1 | 3 | 2 | 2 |
Lumen | 1 | 2 | 3 | 3 | 3 | 2 | 1 | 3 | 1 | 2 |
Periesophageal tissues | 2 | 2 | 3 | 3 | 3 | 2 | 2 | 3 | 2 | 2 |
Tumor signal intensity | No tumor visualized | Intermediate | Intermediate | Intermediate | Intermediate | Intermediate | Intermediate | Intermediate | Intermediate | High (when correlated with histology) |
Tumor position | ||||||||||
MRI | No tumor | Left lateral | Right posterolateral | Right lateral | Right lateral | Posterior | GOJ into left crus | Right lateral | Anterior and both lateral walls | Anterior |
Histology | Microscopic foci | Left lateral | Right posterior | Right lateral | Right lateral | Posterior | Microscopic foci only | Both lateral walls | Circumferential stenotic | Anterior |
Extramural extension | ||||||||||
MRI | Nil | 2 mm | 8 mm | Nil | Nil | Nil | 9 mm | 2 mm | Nil | Nil |
Histology | Nil | Positive margin | 2 mm | 2 mm | Nil | Nil | 4 mm | 3 mm | 1 mm | Nil |
Note—Parameters (rows two through five) were graded as good (3), moderate (2), or poor (1). The tumor position was documented for MRI and histology (pathology). For eight patients MRI correctly located the position of the tumor. Extramural extension of disease was accurately predicted in four out of six patients. A tumor at the gastroesophageal junction was imaged obliquely and interpreted as tumor within the muscularis, whereas the histology showed microscopic disease only. GOJ = gastroesophageal junction, Nil = 0 mm










All interpreters identified signal abnormality on T2-weighted images that corresponded to the site of macroscopic disease pathologically in eight patients. The other two patients had only microscopic foci of disease histologically. Four of the six patients with extramural extension of disease were predicted with MRI, with no false-positive results (Table 1).
Tumor Assessment
MRI signal characteristics—Normal mucosa had intermediate signal intensity surrounded by high-signal-intensity submucosa and low-signal-intensity muscularis propria (Figs. 2A and 2B). Macroscopic tumor returned intermediate signal intensity in seven patients (Figs. 3A and 3B). For all these patients, MRI indicated that the tumor extended into the muscularis propria. This was confirmed histologically in all patients.
In addition, for one patient macroscopic tumor had high signal intensity, and the corresponding histology revealed mucinous adenocarcinoma. For another patient, no abnormality was identifiable on MRI, and histology only showed microscopic tumor foci. A polypoidal region at the gastroesophageal junction in a third patient was interpreted on MRI as macroscopic disease, but histology showed microscopic submucosal tumor only (Table 1).
Correlation with histology—In total, 50 MR images were obtained and matched with histologic slides from the resected specimens. Abnormal intermediate signal intensity identified on T2-weighted MR images (and interpreted as tumor) corresponded to macroscopic tumor pathologically for 13 (26%) of the 50 images and to fibrotic change with microscopic foci of residual tumor for 28 (56%) of them. No demonstrable abnormality was seen on nine MR images (9/50, 18%). The corresponding histology for these nine images showed microscopic foci of tumor (6/9), no tumor (2/9), and widespread submucosal infiltration with mucinous adenocarcinoma (1/9).
The Bland-Altman scatterplots for the three interpreters (Figs. 4A, 4B, and 4C) show the degree of agreement among individual interpreters and histology for measurements of normal esophageal wall and tumor thickness. The plots show better agreement occurred at distances less than 5 mm.


Bland-Altman scatterplots (Figs. 5A, 5B, and 5C) for repeatability of measurements among the three interpreters show good correlation between interpreters 1 and 2 with the mean difference between these interpreters being 0.30 mm (2 SDs ± 5.63).
Analysis of the discrepancies (> ± 2 mm for two or more interpreters) between MRI and pathology measurements of tumor thickness showed underestimation on seven MR images and overestimation on 20 images. Two of the most frequent causes are described and illustrated in Figures 6A, 6B, 7A, and 7B. In addition to the illustrated examples, underestimation resulted from poor visualization of the tumor (two images), and overestimation resulted from inclusion of normal signal wall in the measurement of tumor depth (six images).


Discussion
The study shows that surface-coil MRI of the esophagus is feasible and, when using a T2-weighted sequence, that the esophageal wall layers are accurately depicted and the tumor can be identified separately from surrounding tissue. The results regarding the optimum sequence concur with the in vitro studies performed by Yamada et al. [12, 14]. We chose not to use respiratory or cardiac gating in an attempt to minimize scanning time, which undoubtedly impaired the quality of images obtained. Further work is needed to assess whether this is a satisfactory compromise. We acknowledge that the use of oral and IV contrast media and multiplanar imaging also require investigation to maximize the potential of this technique.
Statistical analysis of the study is limited by the small sample size and the fact that individual patients contributed an average of five of the total 50 images analyzed in the study. Interpretation errors were therefore carried over between the images, exaggerating their impact overall. The appearance of the mucinous tumor, for example, was misinterpreted by all three interpreters, and measurements of tumor depth were underestimated on four MR images as, in each case, high signal intensity within the submucosa was considered to be edema rather than tumor. The measurements taken by the interpreters were at the interface with the unaffected esophageal wall rather than at the maximal extent of the tumor. Overestimation of disease occurred in tumors at the gastroesophageal junction because of the obliquity of the sections. This will undoubtedly remain a difficult area to image, as it is for endoscopic sonography. Further work using tangential MR images at the gastroesophageal junction may provide more accurate assessment of these tumors.
Tumor filling in the esophageal lumen resulted in inaccuracies in tumor measurement because it was difficult to accurately measure the single wall thickness. In reality, it is the mural and, in particular, the extramural component of the tumor that is important for staging and assessment of resectability, and these distances are likely to be more accurately measured.
The discrepancies between interpreters 1 and 2 were essentially for distances greater than 5 mm. At short distances, more important for tumor staging, the correlation between the interpreters was good. Interpreter 3 had 26 years of cross-sectional imaging experience, but had limited previous experience in gastrointestinal MRI, which might explain the wider coefficient of repeatability for interpreter 3 and illustrates that a learning curve is associated with image interpretation.
We acknowledge a limitation within the study design involving interpreter 2, who potentially could have been unblinded by the process of matching the MR images with histology. All attempts were made to prevent this, as explained in the methodology. The results indicate that unblinding is unlikely to have occurred because results from this interpreter were similar to the other two.
Specific correlation with pathologic T staging is required to reinforce the potential of this imaging technique. However, this study has shown that external surface-coil MRI of the esophagus is technically feasible and enables detailed imaging of the esophageal wall, delineation of tumor, and depiction of the surrounding periesophageal tissues.
Acknowledgments
The authors thank Cheryl Richardson and Erica Scurr for their expertise in the development of the MRI technique. We also thank Andrew Norman for his advice regarding the statistical analysis of the study data, Ian Chau for his contribution to the patient treatment protocol that incorporated the MRI study and for his recruitment of patients, and finally Sally Legge for her assistance in the recruitment of patients to the study.
Footnote
Address correspondence to A. M. Riddell ([email protected]).
References
1.
Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001; 94:153-156
2.
Powell J, McConkey CC, Gillison EW, Spychal RT. Continuing rising trend in oesophageal adenocarcinoma. Int J Cancer 2002; 102:422-427
3.
Richards DG, Brown TH, Manson JM. Endoscopic ultrasound in the staging of tumours of the oesophagus and gastro-oesophageal junction. Ann R Coll Surg Engl 2000; 82:311-317
4.
de Manzoni G, Pedrazzani C, Di Leo A, et al. Experience of endoscopic ultrasound in staging adenocarcinoma of the cardia. Eur J Surg Oncol 1999; 25:595-598
5.
Bhutani MS, Barde CJ, Markert RJ, Gopalswamy N. Length of esophageal cancer and degree of luminal stenosis during upper endoscopy predict T stage by endoscopic ultrasound. Endoscopy 2002; 34:461-463
6.
Hunerbein M, Ghadimi BM, Haensch W, Schlag PM. Transendoscopic ultrasound of esophageal and gastric cancer using miniaturized ultrasound catheter probes. Gastrointest Endosc 1998; 48:371-375
7.
Quint LE, Glazer GM, Orringer MB. Esophageal imaging by MR and CT: study of normal anatomy and neoplasms. Radiology 1985; 156:727-731
8.
Takashima S, Takeuchi N, Shiozaki H, et al. Carcinoma of the esophagus: CT vs MR imaging in determining resectability. AJR 1991; 156:297-302
9.
Dave UR, Williams AD, Wilson JA, et al. Esophageal cancer staging with endoscopic MR imaging: pilot study. Radiology 2004; 230:281-286
10.
Kulling D, Feldman DR, Kay CL, et al. Local staging of esophageal cancer using endoscopic magnetic resonance imaging: prospective comparison with endoscopic ultrasound. Endoscopy 1998; 30:745-749
11.
Ozawa S, Imai Y, Suwa T, Kitajima M. What's new in imaging? New magnetic resonance imaging of esophageal cancer using an endoluminal surface coil and antibody-coated magnetite particles. Recent Results Cancer Res 2000; 155:73-87
12.
Yamada I, Murata Y, Izumi Y, et al. Staging of esophageal carcinoma in vitro with 4.7-T MR imaging. Radiology 1997; 204:521-526
13.
Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1:307-310
14.
Yamada I, Izumi Y, Kawano T, et al. Superficial esophageal carcinoma: an in vitro study of high-resolution MR imaging at 1.5T. J Magn Reson Imaging 2001; 13:225-231
Information & Authors
Information
Published In
Copyright
© American Roentgen Ray Society.
History
Submitted: March 30, 2005
Accepted: June 13, 2005
Keywords
Authors
Metrics & Citations
Metrics
Citations
Export Citations
To download the citation to this article, select your reference manager software.